According to statistics, up to 40% of children in European countries experience an allergy to cow’s milk – not to be confused with lactose intolerance, which is a completely different story, accompanied by difficult digestion, flatulence, diarrhea and abdominal pain. “Milk” allergy is a standard allergic clinical manifestation, but this does not make the problem any less unpleasant.
The treatment of such an allergy is not very good at the moment – there are no approved methods. Therefore, scientists have taken up the study of immunocorrection methods and, in particular, subcutaneous immunotherapy in the form of a patch. This method has already shown good results in the fight against peanut allergy.
The first clinical trials were conducted over the course of a year on a small group of children aged 2 to 17 years. The volunteers were divided into one placebo group and three groups with allergen doses of 50 micrograms, 150 and 300. The best results were shown by the participants who received 300 mcg – 24 out of 49 people recorded a primary response to the therapy, only 24.5% of them complained of milk allergy symptoms, and there were no visits to the emergency department among them.